Resveratrol inhibits the phosphatidylinositide 3-kinase/protein kinase B/mammalian target of rapamycin signaling pathway in the human chronic myeloid leukemia K562 cell lineTao Sui(Tianjin First Center Hospital), Xinnv Xu(Tianjin Medical University)Oncology LettersMarch 28, 201410.3892/ol.2014.2014Cited by 33SaveCiteExport RISWatch citationsRelated PapersCD19 CAR-T cell treatment conferred sustained remission in B-ALL patients with minimal residual disease|Cancer Immunology Immunotherapy|2021|22CD19 CAR-T Cells Treatment Conferred a Sustained Remission in Patients with Chemotherapy-Refractory MRD in B-ALL|Blood|2020|0